Clinical outcomes with the use of ticagrelor or clopidogrel after fibrinolytic therapy in patients with ST-elevation myocardial infarction – A prospective observational study

Background: Thrombolytic therapy in the appropriate window period remains the most commonly used therapy in ST-elevation myocardial infarction patients, despite the advantage of primary percutaneous coronary intervention (PCI) over it. Use of newer more potent antiplatelets agents early after thromb...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Bibek Agarwal, Sudarshan Kumar Vijay, Amresh Kumar Singh, Ashish Jha, Bhuwan Chandra Tiwari, Naveen Jamwal
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	Wolters Kluwer Medknow Publications 2022-01-01
Rangatū:	Heart India
Ngā marau:	clopidogrel fibrinolysis ticagrelor
Urunga tuihono:	http://www.heartindia.net/article.asp?issn=2321-449X;year=2022;volume=10;issue=3;spage=152;epage=159;aulast=Agarwal
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!